|Posted on Sunday, September 30, 2007 - 7:54 pm: |
Biography of Stephen R. Drake - Epstein Becker & Green, P.C.
STEPHEN R. DRAKE is a member of the firm in the Health Care and Life Sciences and the Business Law Practices in the firm's Chicago office.
Represents public and privately held clients in securities offerings, mergers and acquisitions, complex business transactions and general corporate matters
Represents biotechnology companies, medical device companies and a variety of technology companies with an emphasis on assisting emerging growth and middle market companies with early-stage, venture and exit financing including IPOs, PIPEs and reverse mergers
Handles federal and state securities law compliance matters in connection with private placements of equity, debt and convertible securities
Practices before the Securities and Exchange Commission, including representing companies in IPOs and other registered securities offerings under the Securities Act of 1933, periodic securities reporting under the Securities and Exchange Act of 1934, and securities filings in connection with mergers and acquisitions
Represents buyers and sellers in all manner of merger, acquisition and divestiture transactions, both domestic and international, including asset sales, stock sales, tax-free mergers, consolidations and joint ventures
Counsels clients with respect to Sarbanes-Oxley compliance and corporate governance.
Recent Representative Matters and Experiences:
Counsel to ethanol producer in $4 million seed financings
Counsel to public food science company in $13 million aggregate PIPE financings
Counsel to private equity fund in exit transaction via $10 million public company merger
Counsel to privately held medical device company in $20 million Series C Preferred Stock financing
Counsel to health insurance company in rights offering to common stockholders
Counsel to privately held medical device company in $3.75 million Series A Preferred Stock financing
Counsel to public biotechnology company in $8 million aggregate PIPE financings
Counsel to manufacturing company in distributor buy-out and redemption transaction financed by $14 million in senior and subordinated debt
Handled federal securities filings for public technology company in connection with a $500 million acquisition
Counsel to public manufacturing company in $55 million business unit divestiture
Counsel to national services firm in $45 million divestiture
Served on the steering committee of the Intermountain Venture Capital Forum
Served on the board of directors of a non-profit organization dedicated to supporting and mentoring technology entrepreneurs.
Publications and Media Interviews:
Regulators Get Aggressive With PIPE Players,The PIPE Report, March 2007
EITF 00-19 Issues Remain, The PIPE Report, December 2006
Several Stock Warrant Restatements Prompted By SEC Review; Equity Versus Liability Classification, BNA Tax, September 2006
Winning Legal Strategies for Life Sciences Settlements and Negotiations (contributing author), Aspatore Books 2006
PIPE Market Adjusts to EITF 00-19: Accounting Rule Increases Costs, Forcing Restatements, Inviting Lawsuits, The PIPEs Report, June 2006
The Long Path From Concept to Patient, Financier Worldwide Biotechnology Review, April 2006
Shaping the Future of Biotechnology, Financier Worldwide Biotechnology Review, April 2006
Implications of EITF 00-19 on Registration Rights Agreements, The PIPEs Report, March 2006
Alternative Public Offerings Roundtable, Financier Worldwide, February 2006
PIPEs: Coming Into Their Own, American Venture Magazine, February 2006
SEC Crackdown Targeting Convertibles on the Books, BioWorld Financial Watch, February 2006
PIPEs: A Crash Course, American Venture Magazine, February 2006
Accounting Standard EITF 00-19 Now Top Priority for the SEC, Martindale-Hubble Counsel to Counsel Corporate Law Alert, February 2006
Accounting Rule Hits Variable Converts, Reg Rights Damages, The PIPEs Report, January 2006.
Prior to joining EBG, Mr. Drake was a member of the Boise, Idaho office of Stoel Rives LLP.